In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery

References

• Babu, S., et al., 2009. Effect of size at the nanoscale and bilayer rigidity on skin diffusion of liposomes. Journal of Biomedical Materials Research. Part A, 91 (1), 140–148.
   PubMedGoogle Scholar
• Barbeau, J., et al., 2011. Preparation and characterization of stealth archaeosomes based on a synthetic PEGylated archaeal tetraether lipid. Journal of Drug Delivery, 2011, 396068.
   PubMedGoogle Scholar
• Blocher, D., et al., 1990. Physicochemical characterization of tetraether lipids from Thermoplasma acidophilum. V. Evidence for the existence of a metastable state in lipids with acyclic hydrocarbon chains. Biochimica et Biophysica Acta, 1024 (1), 54–60.
   PubMedGoogle Scholar
• Carrer, D.C., et al., 2014. Structural features of ultradeformable archaeosomes for topical delivery of ovalbumin. Colloids and Surfaces. B, Biointerfaces, 121, 281–289.
   PubMed Web of Science ®Google Scholar
• Carrer, D.C., Vermehren, C., and Bagatolli, L.A., 2008. Pig skin structure and transdermal delivery of liposomes: a two photon microscopy study. Journal of Controlled Release, 132 (1), 12–20.
   PubMed Web of Science ®Google Scholar
• Choquet, C.G., et al., 1994. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. Applied Microbiology and Biotechnology, 42 (2-3), 375–384.
   PubMed Web of Science ®Google Scholar
• Gillet, A., et al., 2011. Liposome surface charge influence on skin penetration behaviour. International Journal of Pharmaceutics, 411 (1-2), 223–231.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Paredes, A., et al., 2010. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study. Journal of Liposome Research, 20 (4), 269–276.
   PubMed Web of Science ®Google Scholar
• Gurnani, K., et al., 2004. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing. Journal of Immunology, 173 (1), 566–578.
   PubMed Web of Science ®Google Scholar
• Hammond, S.A., et al., 2001. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy. Critical Reviews in Therapeutic Drug Carrier Systems, 18 (5), 503–526.
   PubMed Web of Science ®Google Scholar
• Haq, K., Jia, Y., and Krishnan, L., 2016. Archaeal lipid vaccine adjuvants for induction of cell-mediated immunity. Expert Review of Vaccines, 15 (12), 1557–1566.
   PubMed Web of Science ®Google Scholar
• Higa, L.H., et al., 2016. Ultradeformable archaeosomes for needle free nanovaccination with Leishmania braziliensis antigens. PLoS One, 11 (3), 1-21.
   Web of Science ®Google Scholar
• Higa, L.H., et al., 2012. Ultradeformable archaeosomes as new topical adjuvants. Nanomedicine: Nanotechnology, Biology, and Medicine, 8 (8), 1319–1328.
   PubMed Web of Science ®Google Scholar
• Ishii, F., and Nagasaka, Y., 2001. Simple and convenient method for estimation of marker entrapped in liposomes. Journal of Dispersion Science and Technology, 22, 79–101.
   Web of Science ®Google Scholar
• Krishnan, L., et al., 2000. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infection and Immunity, 68 (1), 54–63.
   PubMed Web of Science ®Google Scholar
• Langworthy, T.A., 1977. Long-chain diglycerol tetraethers from Thermoplasma acidophilum. Biochimica et Biophysica Acta, 487 (1), 37–50.
   PubMedGoogle Scholar
• Lichtenberg, D., and Barenholz, Y., 1988. Liposomes: preparation, characterization, and preservation. Methods of Biochemical Analysis, 33, 337–462.
   PubMedGoogle Scholar
• McCluskie, M.J., Deschatelets, L., and Krishnan, L., 2017. Sulfated archaeal glycolipid archaeosomes as a safe & effective vaccine adjuvant for induction of cell-mediated immunity. Human Vaccines & Immunotherapeutics, 1-8 doi: 10.1080/21645515.2017.1316912
   PubMed Web of Science ®Google Scholar
• Menon, G.K., Cleary, G.W., and Lane, M.E., 2012. The structure and function of the stratum corneum. International Journal of Pharmaceutics, 435 (1), 3–9.
   PubMed Web of Science ®Google Scholar
• Moghimipour, E., et al., 2013. The potent in vitro skin permeation of archaeosome made from lipids extracted of Sulfolobus acidocaldarius. Archaea (Vancouver, B.C.), 2013, 1-7.
   Web of Science ®Google Scholar
• Ogunsola, O.A., et al., 2012. Structural analysis of “flexible” liposome formulations: new insights into the skin-penetrating ability of soft nanostructures. Soft Matter, 8, 10226–10232.
   Web of Science ®Google Scholar
• Patel, G.B., et al., 2000. In vitro assessment of archaeosome stability for developing oral delivery systems. International Journal of Pharmaceutics, 194 (1), 39–49.
   PubMed Web of Science ®Google Scholar
• Patel, G.B., et al., 2002. Safety of archaeosome adjuvants evaluated in a mouse model. Journal of Liposome Research, 12 (4), 353–372.
   PubMed Web of Science ®Google Scholar
• Prausnitz, M.R., and Langer, R., 2008. Transdermal drug delivery. Nature Biotechnology, 26 (11), 1261–1268.
   PubMed Web of Science ®Google Scholar
• Romero, E.L., and Morilla, M.J., 2011. Topical and mucosal liposomes for vaccine delivery. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 3 (4), 356–375.
   PubMed Web of Science ®Google Scholar
• Sabeti, B., et al, 2014. Development and Characterization of Liposomal Doxorubicin Hydrochloride with Palm Oil. BioMed Research International, 2014, 2014, 1-6.
   Web of Science ®Google Scholar
• Sprott, G.D., et al., 1999. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes. Biochimica et Biophysica Acta, 1440 (2-3), 275–288.
   PubMed Web of Science ®Google Scholar
• Sprott, G.D., et al., 2008. Adjuvant potential of archaeal synthetic glycolipid mimetics critically depends on the glyco head group structure. Glycobiology, 18 (7), 559–565.
   PubMed Web of Science ®Google Scholar
• Sprott, G.D., et al., 2003. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen. Archaea (Vancouver, B.C.), 1 (3), 151–164.
   PubMedGoogle Scholar
• Sprott, G.D., Tolson, D.L., and Patel, G.B., 1997. Archaeosomes as novel antigen delivery systems. FEMS Microbiology Letters, 154 (1), 17–22.
   PubMed Web of Science ®Google Scholar
• Sprott, G.D., et al., 2012. Synthetic archaeosome vaccines containing triglycosylarchaeols can provide additive and long-lasting immune responses that are enhanced by archaetidylserine. Archaea, 2012, 1–9.
   Web of Science ®Google Scholar
• Trauer, S., et al., 2014. Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes. European Journal of Pharmaceutics and Biopharmaceutics, 86 (2), 301–306.
   PubMed Web of Science ®Google Scholar
• Van Kuijk-Meuwissen, M.E., Junginger, H.E., and Bouwstra, J.A., 1998. Interactions between liposomes and human skin in vitro, a confocal laser scanning microscopy study. Biochimica et Biophysica Acta, 1371 (1), 31–39.
   PubMed Web of Science ®Google Scholar
• Watson, D.S., Endsley, A.N., and Huang, L., 2012. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine, 30 (13), 2256–2272.
   PubMed Web of Science ®Google Scholar
• Whitfield, D.M., et al., 2010. Development of new glycosylation methodologies for the synthesis of archaeal-derived glycolipid adjuvants. Carbohydrate Research, 345 (2), 214–229.
   PubMed Web of Science ®Google Scholar
• Whitfield, D., Sprott, M.D., and Krishnan, L., 2016. Sulfated-glycolipids as adjuvants for vaccines. World Intellectual Property Organization, WO2016004512 A1(PCT/CA2015/000430):1-83.
   Google Scholar